Pharmacological management of acute agitation (Q34421338)

2 August 2017

1 reference

title

Pharmacological management of acute agitation (English)

1 reference

2 August 2017

1 reference

John Battaglia

1

1 reference

2 August 2017

1 January 2005

1 reference

2 August 2017

1 reference

2 August 2017

65

1 reference

2 August 2017

9

1 reference

2 August 2017

1207-1222

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200565090-00003

2 August 2017

0 references

cites work

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

1 reference

12 December 2020

Impact of atypical antipsychotics on quality of life in patients with schizophrenia

1 reference

12 December 2020

A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy

1 reference

12 December 2020

Midazolam in acute psychotic patients with hyperarousal.

1 reference

12 December 2020

Rapid-acting IM ziprasidone in a psychiatric emergency service: a naturalistic study

1 reference

12 December 2020

Pharmacological management of manic psychosis in an unlocked setting.

1 reference

12 December 2020

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death

1 reference

12 December 2020

Alcohol withdrawal: what is the benzodiazepine of choice?

1 reference

12 December 2020

Comparative study of the effectiveness of zuclopenthixol acetate and haloperidol in acutely disturbed psychotic patients.

1 reference

12 December 2020

Benzodiazepine Poisoning Clinical and Pharmacological Considerations and Treatment

1 reference

12 December 2020

The management of excitement in a general hospital psychiatric ward by high dosage haloperidol

1 reference

12 December 2020

Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior.

1 reference

12 December 2020

Long-acting antipsychotic medication, restraint and treatment in the management of acute psychosis

1 reference

12 December 2020

Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines

1 reference

12 December 2020

Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study

1 reference

12 December 2020

Double-blind comparison of the effects of clonazepam and lorazepam in acute mania

1 reference

12 December 2020

Improving outcome in schizophrenia: the potential importance of EPS and neuroleptic dysphoria

1 reference

12 December 2020

Rapid treatment of acute psychotic symptoms with high- and low-dose haloperidol. Behavioral considerations

1 reference

12 December 2020

Neuroleptic Malignant Syndrome and Atypical Antipsychotic Drugs

1 reference

12 December 2020

Loxapine-lorazepam-induced hypotension and stupor

1 reference

12 December 2020

Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.

1 reference

12 December 2020

Managing the agitated psychotic patient: a reappraisal of the evidence

1 reference

12 December 2020

Violent patients in the emergency setting

1 reference

12 December 2020

The use of midazolam in acutely agitated psychiatric patients.

1 reference

12 December 2020

A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients.

1 reference

12 December 2020

Comparative single-dose pharmacokinetics of clonazepam following intravenous, intramuscular and oral administration to healthy volunteers

1 reference

12 December 2020

Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia

1 reference

12 December 2020

Aggressive dyscontrol in patients treated with benzodiazepines

1 reference

12 December 2020

Critical review of GABA-ergic drugs in the treatment of schizophrenia

1 reference

12 December 2020

Three case reports of behavioral disinhibition with clonazepam

1 reference

12 December 2020

Crisis psychopharmacology techniques.

1 reference

12 December 2020

Rapid parenteral treatment of acute psychosis

1 reference

12 December 2020

The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy

1 reference

12 December 2020

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia

1 reference

12 December 2020

Benzodiazepines combined with neuroleptics for management of severe disruptive behavior

1 reference

12 December 2020

Clinical effectiveness of oral and parenteral rapid neuroleptization

1 reference

12 December 2020

No significant QTc interval changes with high-dose ziprasidone: a case series.

1 reference

12 December 2020

Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients

1 reference

12 December 2020

Glutamate and GABA modulate dopamine in the pedunculopontine tegmental nucleus

1 reference

12 December 2020

Posttraumatic stress disorder following recent-onset psychosis. An unrecognized postpsychotic syndrome

1 reference

12 December 2020

Rapid tranquilization: the efficacy of oral concentrate

1 reference

12 December 2020

Emergency pharmacotherapy of delirium in the critically ill cancer patient

1 reference

12 December 2020

Use of benzodiazepines to control disruptive behavior in inpatients

1 reference

12 December 2020

Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients.

1 reference

12 December 2020

Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study

1 reference

12 December 2020

Droperidol versus haloperidol for chemical restraint of agitated and combative patients

1 reference

12 December 2020

Immediate treatment expedites hospital release

1 reference

12 December 2020

Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial

1 reference

12 December 2020

A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation.

1 reference

12 December 2020

Clonazepam pharmacokinetics, brain uptake, and receptor interactions.

1 reference

12 December 2020

Rapid tranquilization with neuroleptic drugs. Neurologic concerns

1 reference

12 December 2020

Zuclopenthixol acetate (5% in 'Viscoleo'): single-dose treatment for acutely disturbed psychotic patients.

1 reference

12 December 2020

Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans

1 reference

12 December 2020

Clonazepam treatment of chronic schizophrenia: negative results in a double-blind, placebo-controlled trial

1 reference

12 December 2020

Emerging uses for high-potency benzodiazepines in psychotic disorders

1 reference

12 December 2020

Atypical antipsychotics for acute agitation. New intramuscular options offer advantages.

1 reference

12 December 2020

Documentation of violence risk information in psychiatric hospital patient charts: an empirical examination.

1 reference

12 December 2020

A double-blind comparison of the efficacy and safety of lorazepam and diazepam in the treatment of the acute alcohol withdrawal syndrome.

1 reference

12 December 2020

Droperidol causes a dose-dependent prolongation of the QT interval

1 reference

12 December 2020

Treatment of akathisia with lorazepam. An open clinical trial

1 reference

12 December 2020

Respiratory distress with use of lorazepam in mania

1 reference

12 December 2020

A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population

1 reference

12 December 2020

Intramuscular ziprasidone: moving beyond the conventional in the treatment of acute agitation in schizophrenia.

1 reference

12 December 2020

Clinical significance of drug binding, protein binding, and binding displacement drug interactions

1 reference

12 December 2020

gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Droperidol vs. haloperidol in the initial management of acutely agitated patients.

1 reference

12 December 2020

Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation

1 reference

12 December 2020

Diazepam potentiates the effect of neuroleptics on behavioural activity as well as dopamine and norepinephrine turnover: Do benzodiazepines have antipsychotic potency?

1 reference

12 December 2020

Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting

1 reference

12 December 2020

Therapeutic window of serum haloperidol concentration in acute schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation.

1 reference

12 December 2020

Droperidol in acutely agitated patients. A double-blind placebo-controlled study

1 reference

12 December 2020

Droperidol: efficacy and side effects in psychiatric emergencies

1 reference

12 December 2020

Safety and efficacy of high-dose droperidol in agitated patients

1 reference

12 December 2020

Calming versus sedative effects of intramuscular olanzapine in agitated patients

1 reference

12 December 2020

Risk factors and correlates of violence among acutely ill adult psychiatric inpatients

1 reference

12 December 2020

Further experience and observations with lorazepam in the management of behavioral agitation

1 reference

12 December 2020

Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a double-blind, randomized study in acutely agitated patients with dementia.

1 reference

12 December 2020

Benzodiazepines in the treatment of schizophrenia: a review and reappraisal

1 reference

12 December 2020

Pharmacokinetic Comparison of Sublingual Lorazepam with Intravenous, Intramuscular, and Oral Lorazepam

1 reference

12 December 2020

The pathophysiology of agitation

1 reference

12 December 2020

Using antipsychotic agents in older patients

1 reference

12 December 2020

Evaluating the usage of droperidol in acutely agitated persons with brain injury

1 reference

12 December 2020

The use of benzodiazepines for psychotic disorders: a literature review and preliminary clinical findings

1 reference

12 December 2020

Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior

1 reference

12 December 2020

A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms

1 reference

12 December 2020

A comparison of two adjunctive treatment strategies in acute mania

1 reference

12 December 2020

Rational use of benzodiazepines in the elderly

1 reference

12 December 2020

Benzodiazepines and acute psychotic agitation

1 reference

12 December 2020

Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia

1 reference

12 December 2020

Neuroleptic malignant syndrome

1 reference

12 December 2020

A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania

1 reference

12 December 2020

Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature

1 reference

12 December 2020

Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected

1 reference

12 December 2020

Acute high-dose parenteral haloperidol treatment of psychosis

1 reference

12 December 2020

Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group.

1 reference

12 December 2020

10.2165/00003495-200565090-00003

Identifiers

DOI

1 reference

PubMed ID

15916448

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

15916448